Influence of patient-reported outcomes on market access decisions in decentralized markets (Brazil, Italy, Spain, and the United States)

Andrew P. Brogan; Susan L. Hogue; Susan L. Hogue; Andrew P. Brogan; C DeMuro; A Barrett; D D'Alessio; V Bal

Influence of patient-reported outcomes on market access decisions in decentralized markets (Brazil, Italy, Spain, and the United States)

Hogue, S., Brogan, A., DeMuro, C., Barrett, A., D'Alessio, D., & Bal, V. (2015). Influence of patient-reported outcomes on market access decisions in decentralized markets (Brazil, Italy, Spain, and the United States). Value in Health, 18(3), A212-A212. https://doi.org/10.1016/j.jval.2015.03.1229

Copy citation

Abstract

To determine how impactful patient-reported outcome (PRO) data from clinical trial programs are on market access decision making in oncology and other disease areas in decentralized markets.